Common Side Effects in Children
Genotropin (somatropin), a growth hormone used to treat growth failure in children, can cause injection-site reactions like pain, redness, or swelling in up to 30-50% of pediatric patients during early treatment.[1] Headaches occur in about 15-20%, often mild and resolving over time. Joint or muscle pain affects 10-15%, linked to rapid growth spurt effects.[2]
Serious Risks and Long-Term Concerns
Increased intracranial pressure (pseudotumor cerebri) happens in 1-5% of children, with symptoms like severe headaches, vision changes, or nausea—requiring immediate medical attention to avoid permanent vision loss.[1][3] Scoliosis risk rises in children with rapid height gains, as spinal growth outpaces stability; screening is recommended every 3-6 months.[2]
Type 2 diabetes risk elevates due to somatropin's insulin resistance effects, especially in predisposed kids—monitor blood glucose regularly.[1] Slipped capital femoral epiphysis, a hip joint issue causing pain and limp, occurs in under 1% but demands urgent orthopedic care.[3]
Cancer and Mortality Risks
Prior malignancy recurrence is a concern; Genotropin is contraindicated in active cancer but debated for history of cancer—long-term studies show no clear increased relapse in non-cancer growth disorders.[4] A 2002 FDA analysis of over 18,000 children found 11 deaths from leukemia (versus expected 4.3), though causality unproven and risk appears low (about 1 in 5,000).[5] No broad cancer signal in post-marketing data.[1]
Growth-Related and Monitoring Issues
Over-rapid growth can cause orthopedic problems like Legg-Calve-Perthes disease (hip blood supply disruption). Hypothyroidism may unmask, slowing response—thyroid tests needed at start and yearly.[2] Fluid retention leads to edema in 5-10%.[3]
Who Should Avoid It
Contraindicated in acute critical illness, active malignancy, or closed epiphyses. Use caution in Prader-Willi syndrome (increased choking/aspiration risk, 1-2% mortality from respiratory issues).[1] Black-box warning for mortality increase in critically ill kids.[6]
[1]: Genotropin Prescribing Information (Pfizer)
[2]: FDA Growth Hormone Safety Review
[3]: Pediatric Endocrine Society Guidelines
[4]: NEJM Study on GH and Cancer Risk
[5]: FDA 2002 SAG Report
[6]: DailyMed Genotropin Label